Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02954874
Brief Title: Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

First Submitted : November 3, 2016
First Submitted that Met QC Criteria : November 3, 2016
First Posted : November 4, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 15, 2019
Last Update Posted : October 16, 2019